Aylin Yildirir Selected Research

Aylin Yildirir Research Topics

Disease

12	Coronary Artery Disease (Coronary Atherosclerosis) 02/2019 - 12/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 02/2019 - 10/2004
5	Acute Coronary Syndrome 02/2019 - 01/2007
5	Hypertension (High Blood Pressure) 02/2019 - 08/2005
5	Chronic Kidney Failure (Chronic Renal Failure) 02/2009 - 03/2004
4	Myocardial Infarction 02/2019 - 02/2008
4	Atrial Fibrillation 05/2008 - 10/2005
4	Heart Failure 02/2008 - 10/2004
2	Pathologic Constriction (Stenosis) 02/2018 - 09/2002
2	Atherosclerosis 03/2010 - 04/2008
2	Necrosis 09/2009 - 01/2008
2	Aortic Valve Stenosis (Aortic Stenosis) 07/2008 - 10/2004
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2007 - 03/2007
2	Vascular Diseases (Vascular Disease) 10/2004 - 12/2002
1	Hyperlipidemias (Hyperlipidemia) 02/2019
1	Atherosclerotic Plaque (Atheroma) 02/2019
1	Disease Progression 02/2019
1	Goiter 06/2016
1	End Stage Liver Disease 06/2010
1	Type 2 Diabetes Mellitus (MODY) 06/2010
1	Non-ST Elevated Myocardial Infarction 09/2009
1	Unstable Angina 09/2009
1	Microvascular Angina (Cardiac Syndrome X) 04/2009
1	Inflammation (Inflammations) 11/2008
1	Appendicitis 04/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2008
1	Death (Near-Death Experience) 02/2008
1	Heart Diseases (Heart Disease) 02/2008
1	Hypothyroidism 11/2007
1	Hypercholesterolemia 09/2007
1	Left Ventricular Dysfunction 03/2007
1	Ischemia 02/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2007
1	Dyspnea (Shortness of Breath) 01/2007
1	Cardiac Arrhythmias (Arrythmia) 01/2007
1	Insulin Resistance 04/2006
1	Renal Insufficiency (Renal Failure) 03/2006
1	Bundle-Branch Block (Fascicular Block) 07/2005
1	Brugada Syndrome 07/2005
1	Alzheimer Disease (Alzheimer's Disease) 10/2004
1	Osteoporosis 10/2004
1	Hemorrhage 01/2002

Drug/Important Bio-Agent (IBA)

4	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2008 - 01/2007
3	omega-Chloroacetophenone (Mace)IBA 02/2019 - 02/2008
3	C-Reactive ProteinIBA 02/2019 - 09/2002
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2009 - 01/2007
3	Uric Acid (Urate)IBA 04/2009 - 01/2007
2	TransferasesIBA 02/2019 - 11/2008
2	CholesterolIBA 06/2010 - 03/2010
2	Estrogens (Estrogen)FDA Link 03/2010 - 01/2002
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 07/2008 - 12/2007
2	Metoprolol (Toprol-XL)FDA LinkGeneric 05/2008 - 08/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2007 - 10/2004
2	HomocysteineIBA 08/2005 - 12/2002
1	OsteopontinIBA 02/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 06/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2010
1	LDL CholesterolIBA 06/2010
1	Indicators and Reagents (Reagents)IBA 02/2009
1	Carvedilol (Coreg)FDA LinkGeneric 05/2008
1	Lipoprotein(a)IBA 04/2008
1	Thyroid HormonesIBA 11/2007
1	Nebivolol FDA Link 03/2007
1	Protein CIBA 02/2007
1	Clostridium perfringens epsilon-toxinIBA 01/2007
1	LipidsIBA 04/2006
1	Insulin (Novolin)FDA Link 04/2006
1	Blood Group Antigens (Blood Groups)IBA 04/2006
1	HDL CholesterolIBA 04/2006
1	Protein Isoforms (Isoforms)IBA 03/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2006
1	EnzymesIBA 03/2006
1	MyoglobinIBA 03/2006
1	Biomarkers (Surrogate Marker)IBA 03/2006
1	Serum AlbuminIBA 01/2006
1	HDL LipoproteinsIBA 01/2006
1	Ajmaline (Wolfina)FDA Link 07/2005
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2005
1	Dobutamine FDA LinkGeneric 01/2005
1	ThalliumIBA 10/2004
1	TroponinIBA 10/2004
1	MB Form Creatine KinaseIBA 10/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2002
1	InterleukinsIBA 09/2002
1	Fibrinogen (Factor I)FDA Link 09/2002
1	CytokinesIBA 09/2002
1	Progesterone FDA LinkGeneric 01/2002

Therapy/Procedure

5	Therapeutics 06/2016 - 08/2005
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2008 - 10/2005
3	Renal Dialysis (Hemodialysis) 01/2007 - 03/2004
2	Stents 02/2018 - 09/2002
2	Percutaneous Coronary Intervention 02/2008 - 01/2007
2	Kidney Transplantation 03/2006 - 10/2004
1	Liver Transplantation 06/2010
1	Length of Stay 05/2008
1	Appendectomy 04/2008
1	Secondary Prevention 10/2004